301520 万邦医药
已收盘 02-06 15:00:00
资讯
新帖
简况
万邦医药：截止2026年1月30日，公司的股东人数为7,983户
证券之星 · 02-03
万邦医药：截止2026年1月30日，公司的股东人数为7,983户
股市必读：万邦医药（301520）预计2025年全年归属净利润盈利2861.17万元至4216.46万元
证券之星 · 02-02
股市必读：万邦医药（301520）预计2025年全年归属净利润盈利2861.17万元至4216.46万元
万邦医药（301520）披露2025年度业绩预告，1月30日股价上涨1.13%
证券之星 · 01-30
万邦医药（301520）披露2025年度业绩预告，1月30日股价上涨1.13%
万邦医药（301520）披露公司控制的合伙企业认购私募基金份额进展公告，1月28日股价下跌2.57%
证券之星 · 01-28
万邦医药（301520）披露公司控制的合伙企业认购私募基金份额进展公告，1月28日股价下跌2.57%
万邦医药：截止2026年1月20日股东人数为8,504户
证券之星 · 01-22
万邦医药：截止2026年1月20日股东人数为8,504户
万邦医药：公司始终高度重视股东利益与市值管理
证券日报 · 01-19
万邦医药：公司始终高度重视股东利益与市值管理
万邦医药（301520）公司公告披露使用部分超募资金永久补充流动资金，1月14日股价下跌2.12%
证券之星 · 01-14
万邦医药（301520）公司公告披露使用部分超募资金永久补充流动资金，1月14日股价下跌2.12%
万邦医药：截止2026年1月9日股东人数为7,686户
证券之星 · 01-13
万邦医药：截止2026年1月9日股东人数为7,686户
万邦医药(301520)12月31日股东户数0.78万户，较上期减少0.28%
证券之星 · 01-06
万邦医药(301520)12月31日股东户数0.78万户，较上期减少0.28%
万邦医药：截至2025年12月31日股东人数为7,790户
证券之星 · 01-05
万邦医药：截至2025年12月31日股东人数为7,790户
万邦医药（301520）披露召开2026年第一次临时股东会通知，12月25日股价上涨0.8%
证券之星 · 2025-12-25
万邦医药（301520）披露召开2026年第一次临时股东会通知，12月25日股价上涨0.8%
万邦医药：截至2025年12月19日股东人数为7,812户
证券之星 · 2025-12-22
万邦医药：截至2025年12月19日股东人数为7,812户
万邦医药：截止2025年12月10日股东人数为7,945户
证券之星 · 2025-12-11
万邦医药：截止2025年12月10日股东人数为7,945户
万邦医药：截至2025年11月28日股东人数为7,963户
证券之星 · 2025-12-01
万邦医药：截至2025年11月28日股东人数为7,963户
万邦医药：截止2025年11月20日股东人数为7,989户
证券之星 · 2025-11-21
万邦医药：截止2025年11月20日股东人数为7,989户
万邦医药：截止2025年10月31日股东人数为8,277户
证券之星 · 2025-11-04
万邦医药：截止2025年10月31日股东人数为8,277户
万邦医药（301520）2025年三季报简析：净利润同比下降57.44%，三费占比上升明显
证券之星 · 2025-10-24
万邦医药（301520）2025年三季报简析：净利润同比下降57.44%，三费占比上升明显
万邦医药：截止2025年10月20日股东人数为8,174户
证券之星 · 2025-10-23
万邦医药：截止2025年10月20日股东人数为8,174户
万邦医药(301520.SZ)发布前三季度业绩，归母净利润3311.06万元，下降57.44%
智通财经 · 2025-10-22
万邦医药(301520.SZ)发布前三季度业绩，归母净利润3311.06万元，下降57.44%
股市必读：万邦医药（301520）10月16日董秘有最新回复
证券之星 · 2025-10-17
股市必读：万邦医药（301520）10月16日董秘有最新回复
加载更多
公司概况
公司名称：
安徽万邦医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2023-09-25
主营业务：
安徽万邦医药科技股份有限公司的主营业务是药学研究和临床研究服务的综合型CRO，通过合同形式为医药企业和其他医药研发机构提供专业化医药研发外包服务。公司的主要产品是临床试验现场管理（SMO）、生物样本分析（BA）、数据管理与统计分析（DM/ST）、处方工艺研究、质量研究、稳定性研究。
发行价格：
67.88
{"stockData":{"symbol":"301520","market":"SZ","secType":"STK","nameCN":"万邦医药","latestPrice":44.68,"timestamp":1770361401000,"preClose":44.3,"halted":0,"volume":901562,"delay":0,"changeRate":0.0086,"floatShares":22423000,"shares":66666700,"eps":0.6127,"marketStatus":"已收盘","change":0.38,"latestTime":"02-06 15:00:00","open":44.33,"high":45.16,"low":44.07,"amount":40399700,"amplitude":0.0246,"askPrice":44.7,"askSize":1,"bidPrice":44.66,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.6127,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":44.3,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":48.73,"lowLimit":39.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":66666667,"isCdr":false,"pbRate":1.95,"roa":"--","peRate":72.923127,"roe":"2.21%","epsLYR":1.28,"committee":0.018868,"marketValue":2979000000,"turnoverRate":0.0402,"status":0,"floatMarketCap":1002000000},"requestUrl":"/m/hq/s/301520","defaultTab":"news","newsList":[{"id":"2608847655","title":"万邦医药：截止2026年1月30日，公司的股东人数为7,983户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608847655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608847655?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:00","pubTimestamp":1770102042,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年一月 30日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2026年1月30日，公司的股东人数为7,983户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300019953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2608889735","title":"股市必读：万邦医药（301520）预计2025年全年归属净利润盈利2861.17万元至4216.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608889735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608889735?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:56","pubTimestamp":1769975771,"startTime":"0","endTime":"0","summary":"来自公司公告汇总：公司预计2025年扣非后净利润最低仅744.61万元，同比下降超八成。业绩披露要点业绩预告万邦医药发布业绩预告，预计2025年全年归属净利润盈利2861.17万元至4216.46万元。公司公告汇总2025年度业绩预告安徽万邦医药科技股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为2,861.17万元至4,216.46万元，比上年同期下降50.70%-66.55%；扣除非经常性损益后的净利润为744.61万元至1,097.32万元，同比下降80.33%-86.65%。最终数据以2025年年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520"],"gpt_icon":0},{"id":"2607044000","title":"万邦医药（301520）披露2025年度业绩预告，1月30日股价上涨1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607044000","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607044000?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:12","pubTimestamp":1769785936,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，万邦医药报收于44.72元，较前一交易日上涨1.13%，最新总市值为29.81亿元。该股当日开盘44.0元，最高45.11元，最低43.9元，成交额达4975.96万元，换手率为4.97%。近日，安徽万邦医药科技股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为2,861.17万元至4,216.46万元，比上年同期下降50.70%-66.55%；扣除非经常性损益后的净利润为744.61万元至1,097.32万元，同比下降80.33%-86.65%。最终数据以2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2606279469","title":"万邦医药（301520）披露公司控制的合伙企业认购私募基金份额进展公告，1月28日股价下跌2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606279469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606279469?lang=zh_cn&edition=full","pubTime":"2026-01-28 17:41","pubTimestamp":1769593262,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，万邦医药报收于43.99元，较前一交易日下跌2.57%，最新总市值为29.33亿元。该股当日开盘45.15元，最高45.15元，最低43.77元，成交额达4442.27万元，换手率为4.48%。万邦医药于近日披露《关于公司控制的合伙企业认购私募基金份额的进展公告》。公告显示，安徽万邦医药科技股份有限公司控制的合肥群象齐鸣企业管理合伙企业于2025年12月22日签署协议，以自有资金认缴出资1,000万元参与认购嘉兴隆峰创业投资合伙企业基金份额，认缴比例为12.987%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800030635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2605445456","title":"万邦医药：截止2026年1月20日股东人数为8,504户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605445456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605445456?lang=zh_cn&edition=full","pubTime":"2026-01-22 11:34","pubTimestamp":1769052857,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司到1月20日的股东人数，谢谢万邦医药回复：尊敬的投资者您好！截止2026年1月20日，公司的股东人数为8,504户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200015169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2604136611","title":"万邦医药：公司始终高度重视股东利益与市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2604136611","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604136611?lang=zh_cn&edition=full","pubTime":"2026-01-19 20:34","pubTimestamp":1768826040,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯 1月19日，万邦医药在互动平台回答投资者提问时表示，公司始终高度重视股东利益与市值管理，致力于通过稳健经营提升内在价值，切实维护投资者利益。公司持续关注AI医疗等领域，未来如涉及应披露的重大事项，将根据相关规定及时履行信息披露义务，请以公司公告为准。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-19/doc-inhhwavt9663242.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-19/doc-inhhwavt9663242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2603612666","title":"万邦医药（301520）公司公告披露使用部分超募资金永久补充流动资金，1月14日股价下跌2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612666","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603612666?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:36","pubTimestamp":1768401370,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，万邦医药报收于45.23元，较前一交易日下跌2.12%，最新总市值为30.15亿元。该股当日开盘45.22元，最高47.45元，最低44.46元，成交额达2.18亿元，换手率为21.18%。近日，安徽万邦医药科技股份有限公司发布2026年第一次临时股东会决议公告，宣布会议审议通过了使用部分超募资金永久补充流动资金的议案。此次临时股东会于2026年1月14日召开，由董事会召集，董事长陶春蕾主持，出席股东及授权代表共71人，代表有表决权股份总数的62.8707%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2603505189","title":"万邦医药：截止2026年1月9日股东人数为7,686户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603505189","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603505189?lang=zh_cn&edition=full","pubTime":"2026-01-13 15:36","pubTimestamp":1768289805,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年1月9日，公司股东数是多少？万邦医药回复：尊敬的投资者您好！截止2026年1月9日，公司的股东人数为7,686户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300020459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2601597893","title":"万邦医药(301520)12月31日股东户数0.78万户，较上期减少0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601597893","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601597893?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:43","pubTimestamp":1767692630,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万邦医药披露，截至2025年12月31日公司股东户数为7790.0户，较12月19日减少22.0户，减幅为0.28%。在医疗服务行业个股中，万邦医药股东户数低于行业平均水平，截至12月31日，医疗服务行业平均股东户数为4.51万户。从股价来看，2025年12月19日至2025年12月31日，万邦医药区间跌幅为0.82%，在此期间股东户数减少22.0户，减幅为0.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600029905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2601005550","title":"万邦医药：截至2025年12月31日股东人数为7,790户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601005550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601005550?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:27","pubTimestamp":1767598032,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)01月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2025年12月31日，公司的股东人数为7,790户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2594383230","title":"万邦医药（301520）披露召开2026年第一次临时股东会通知，12月25日股价上涨0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594383230","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594383230?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:58","pubTimestamp":1766674698,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，万邦医药报收于40.24元，较前一交易日上涨0.8%，最新总市值为26.83亿元。该股当日开盘39.92元，最高40.38元，最低39.8元，成交额达1258.74万元，换手率为1.4%。公司近日发布公告，宣布将于2026年1月14日召开2026年第一次临时股东会，会议将采取现场表决与网络投票相结合的方式进行。股权登记日为2026年1月8日。公告指出，中小投资者的表决结果将单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2593872107","title":"万邦医药：截至2025年12月19日股东人数为7,812户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593872107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593872107?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:54","pubTimestamp":1766390075,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月20日的股东人数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2025年12月19日，公司的股东人数为7,812户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200013474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2590952475","title":"万邦医药：截止2025年12月10日股东人数为7,945户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590952475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590952475?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:36","pubTimestamp":1765442168,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日公司股东人数多少？万邦医药回复：尊敬的投资者您好！截止2025年12月10日，公司的股东人数为7,945户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100024301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2588747416","title":"万邦医药：截至2025年11月28日股东人数为7,963户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747416?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:12","pubTimestamp":1764576731,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十一月 28日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2025年11月28日，公司的股东人数为7,963户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2585113407","title":"万邦医药：截止2025年11月20日股东人数为7,989户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113407","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585113407?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:45","pubTimestamp":1763714737,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十一月 20日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2025年11月20日，公司的股东人数为7,989户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100022074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2580992272","title":"万邦医药：截止2025年10月31日股东人数为8,277户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580992272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580992272?lang=zh_cn&edition=full","pubTime":"2025-11-04 11:33","pubTimestamp":1762227207,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止10月31日股东户数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2025年10月31日，公司的股东人数为8,277户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400014526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2577537919","title":"万邦医药（301520）2025年三季报简析：净利润同比下降57.44%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2577537919","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577537919?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:07","pubTimestamp":1761257255,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期万邦医药发布2025年三季报。截至本报告期末，公司营业总收入2.09亿元，同比下降28.6%，归母净利润3311.06万元，同比下降57.44%。按单季度数据看，第三季度营业总收入6258.77万元，同比下降41.0%，第三季度归母净利润629.92万元，同比下降72.33%。本报告期万邦医药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达53.08%。去年的净利率为22.56%，算上全部成本后，公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520"],"gpt_icon":0},{"id":"2577341367","title":"万邦医药：截止2025年10月20日股东人数为8,174户","url":"https://stock-news.laohu8.com/highlight/detail?id=2577341367","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577341367?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:55","pubTimestamp":1761180913,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十月 20日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2025年10月20日，公司的股东人数为8,174户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300006402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2577553369","title":"万邦医药(301520.SZ)发布前三季度业绩，归母净利润3311.06万元，下降57.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577553369","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577553369?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:44","pubTimestamp":1761133478,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦医药(301520.SZ)发布2025年三季度报告，该公司前三季度营业收入为2.09亿元，同比减少28.60%。归属于上市公司股东的净利润为3311.06万元，同比减少57.44%。归属于上市公司股东的扣除非经常性损益的净利润为844.92万元，同比减少84.89%。基本每股收益为0.5元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"万邦医药(301520.SZ)发布前三季度业绩，归母净利润3311.06万元，下降57.44%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301520"],"gpt_icon":0},{"id":"2576738847","title":"股市必读：万邦医药（301520）10月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576738847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576738847?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:10","pubTimestamp":1760645419,"startTime":"0","endTime":"0","summary":"截至2025年10月16日收盘，万邦医药报收于41.49元，上涨0.12%，换手率3.06%，成交量6870.0手，成交额2846.57万元。董秘最新回复投资者： 董秘您好，请问公司有研究抗癌药物吗？公司是一家CRO企业，主营业务是为医药企业及研发机构提供专业化医药研发外包服务，承接过的项目包括为客户提供肿瘤患者用药的临床试验研究技术服务，不涉及自主研发抗癌药物。交易信息汇总资金流向10月16日主力资金净流入80.56万元；游资资金净流入258.58万元；散户资金净流出339.15万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700004157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770565523554,"stockEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0892},{"period":"3month","weight":0.0469},{"period":"6month","weight":-0.043},{"period":"1year","weight":0.1418},{"period":"ytd","weight":0.1246}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽万邦医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"7983人(较上一季度减少6.13%)","perCapita":"2808股","listingDate":"2023-09-25","address":"安徽省合肥市蜀山区高新区火龙地路299号","registeredCapital":"6666万元","survey":" 安徽万邦医药科技股份有限公司的主营业务是药学研究和临床研究服务的综合型CRO，通过合同形式为医药企业和其他医药研发机构提供专业化医药研发外包服务。公司的主要产品是临床试验现场管理（SMO）、生物样本分析（BA）、数据管理与统计分析（DM/ST）、处方工艺研究、质量研究、稳定性研究。","listedPrice":67.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦医药,301520,万邦医药股票,万邦医药股票老虎,万邦医药股票老虎国际,万邦医药行情,万邦医药股票行情,万邦医药股价,万邦医药股市,万邦医药股票价格,万邦医药股票交易,万邦医药股票购买,万邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}